A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy

Affiliations

• ¹ Department of Individualized Cancer Management, Moffitt Cancer Center, Tampa, Florida, USA.
• ² Department of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
• ³ Department of Pharmacy Practice, MCPHS University School of Pharmacy, Boston, Massachusetts, USA.
• ⁴ Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
• ⁵ Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
• ⁶ Departments of Medical Genetics Psychiatry, Physiology & Pharmacology, University of Calgary, Calgary, Alberta, Canada.
• ⁷ Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada.
• ⁸ Mathison Centre for Mental Health Research and Education, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
• ⁹ Division of Clinical Pharmacology, Toxicology, & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.
• ¹⁰ CIBERSAM, Madrid, Spain.
• ¹¹ CICAB Clinical Research Center, Extremadura University Hospital and Medical School, Badajoz, Spain.
• ¹² Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
• ¹³ Department of Psychiatry, University of Toronto, Ontario, Canada.
• ¹⁴ Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
• ¹⁵ Divisions of Research in Patient Services and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
• ¹⁶ Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
• ¹⁷ Sema4, a Mount Sinai Venture, Stamford, Connecticut, USA.
• ¹⁸ Department of Medicine, Indiana University, Indianapolis, Indiana, USA.